3Buller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest,2004,126(3 Suppl):401S-428S.
4British thoracic society guidelines for the management of suspected acute pulmonary embolism. Thorax,2003, 58:470-483.
5Goldhaber SZ. Pulmonary embolism. Lancet,2004, 363:1295-1305.
6Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology. Eur Heart J,2000, 21:1301-1336.
7Stein PD, Afzal A, Henry JW, et al. Fever in acute pulmonary embolism. Chest,2000, 117:39.
8Kucher N, Goldhaber SZ. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation,2003, 108:2191-2194.
9Rodger M, Makropoulos D, Turek M, et al. Diagnostic value of the electrocardiogram in suspected pulmonary embolism.Am J Cardiol,2000, 86:807-809.
1European society of cardiology.Guidelines on diagnosis and management of acute pulmonary embolism[J].European Heart J, 2008, 29(18) : 2276- 2315.
2Siverstien M D, Heit J A, Mohr D N, et al.Trends in the incidence of deep vien thrombosis and pulmonary embolism[J].Arch Intern Med, 1998, 158(6) : 585-593.
3Konstantinides S, Geibel A, Olschewski M, et al.Importance of cardiac troponins I and T in risk stratification of patients with pulmonary embolism[J].Circulation, 2002, 106(10):1263-1265.
